1. Home
  2. ASTI vs RNAZ Comparison

ASTI vs RNAZ Comparison

Compare ASTI & RNAZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ascent Solar Technologies Inc.

ASTI

Ascent Solar Technologies Inc.

HOLD

Current Price

$2.14

Market Cap

30.0M

Sector

Technology

ML Signal

HOLD

Logo TransCode Therapeutics Inc.

RNAZ

TransCode Therapeutics Inc.

SELL

Current Price

$1.63

Market Cap

27.9M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
ASTI
RNAZ
Founded
2005
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
30.0M
27.9M
IPO Year
2014
2021

Fundamental Metrics

Financial Performance
Metric
ASTI
RNAZ
Price
$2.14
$1.63
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 254.9K
48.0K
Earning Date
11-09-2026
08-14-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 70.23
N/A
EPS
★ N/A
N/A
Revenue
★ $10,398,149.00
N/A
Revenue This Year
$987.62
N/A
Revenue Next Year
$2,579.52
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 163.25
N/A
52 Week Low
$1.40
$1.52
52 Week High
$9.87
$15.90

Technical Indicators

Market Signals
Indicator
ASTI
RNAZ
Relative Strength Index (RSI) 30.14 41.61
Support Level N/A $1.55
Resistance Level $3.22 $2.39
Average True Range (ATR) 0.19 0.21
MACD -0.03 0.10
Stochastic Oscillator 5.86 24.14

Price Performance

Historical Comparison
ASTI
RNAZ

About ASTI Ascent Solar Technologies Inc.

Ascent Solar Technologies Inc is a solar technology company that manufactures and sells photovoltaic (PV) solar modules that are flexible, durable, and possess attractive power to weight and power to area performance. Its technology provides renewable power solutions to high-value production and specialty solar markets where traditional rigid solar panels are not suitable, including space power beaming, aerospace, satellites, near earth orbiting vehicles, fixed wing unmanned aerial vehicles (UAV), aquatic, terrestrial, and other weight-sensitive markets with transformational high quality, value added product applications. It operates in single PV segment that sells PV products and engineering services and currently, is selling it in North America.

About RNAZ TransCode Therapeutics Inc.

TransCode Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of RNA-based therapeutics and immuno-oncology treatments for cancer. The company's lead candidate, TTX-MC138, targets microRNA-10b and has completed a Phase 1a clinical trial, while it is also advancing additional product candidates, including a cancer vaccine and an oncolytic immunotherapy platform.

Share on Social Networks: